Stephen Rollnick

Bio: Stephen Rollnick is an academic researcher from Cardiff University. The author has contributed to research in topics: Motivational interviewing & Behavior change. The author has an hindex of 56, co-authored 125 publications receiving 31367 citations. Previous affiliations of Stephen Rollnick include University of Wales & National Drug and Alcohol Research Centre.

Motivational interviewing: preparing people for change.

Abstract: Part I: Context. Why Do People Change? Ambivalence: The Dilemma of Change. Facilitating Change. Part II: Practice. What is Motivational Interviewing? Change and Resistance: Opposite Sides of the Coin. Phase 1: Building Motivation for Change. Responding to Change Talk. Responding to Resistance. Enhancing Confidence. Phase 2: Strengthening Commitment to Change. A Practical Case Example. Ethical Considerations. Part III: Learning Motivational Interviewing. Reflections on Learning. Facilitating Learning. Part IV: Applications of Motivational Interviewing. DiClemente, Velasquez, Motivational Interviewing and the Stages of Change. Burke, Arkowitz, Dunn, The Efficacy of Motivational Interviewing and its Adaptations: What we Know So Far. Resnicow, DiIorio, Soet, Borrelli, Ernst, Hecht, Thevos, Motivational Interviewing in Medical and Public Health Settings. Rollnick, Allison, Ballasiotes, Barth, Butler, Rose, Rosengren, Variations on a Theme: Motivational Interviewing and its Adaptations. Wagner, Sanchez, The Role of Values in Motivational Interviewing. Zweben, Zuckoff, Motivational Interviewing and Treatment Adherence. Baer, Peterson, Motivational Interviewing with Adolescents and Young Adults. Ginsburg, Mann, Rotgers, Weekes, Motivational Interviewing with Criminal Justice Populations. Burke, Vassilev, Kantchelov, Zweben, Motivational Interviewing with Couples. Handmaker, Packard, Conforti, Motivational Interviewing in the Treatment of Dual Disorders. Walters, Ogle, Martin, Perils and Possibilities of Group-Based Motivational Interviewing.

Motivational Interviewing: Preparing People to Change Addictive Behavior

Abstract: Since the initial publication of this classic text, motivational interviewing (MI) has been used by countless clinicians in diverse settings. Theory and methods have evolved apace, reflecting new knowledge on the process of behavior change, a growing body of outcome research, and the development of new applications within and beyond the addictions field. Including 25 nearly all-new chapters, this revised and expanded second edition now brings MI practitioners and trainees fully up to date. William R. Miller and Stephen Rollnick explain how to work through ambivalence to facilitate change, present detailed guidelines for using their approach with a variety of clinical populations, and reflect on the process of learning MI. Chapters contributed by other leading experts then address such special topics as MI and the stages-of-change model; using the approach with groups, couples, and adolescents; and applications to general medical care, health promotion, and criminal justice settings.

Shared Decision Making: A Model for Clinical Practice

Abstract: The principles of shared decision making are well documented but there is a lack of guidance about how to accomplish the approach in routine clinical practice. Our aim here is to translate existing conceptual descriptions into a three-step model that is practical, easy to remember, and can act as a guide to skill development. Achieving shared decision making depends on building a good relationship in the clinical encounter so that information is shared and patients are supported to deliberate and express their preferences and views during the decision making process. To accomplish these tasks, we propose a model of how to do shared decision making that is based on choice, option and decision talk. The model has three steps: a) introducing choice, b) describing options, often by integrating the use of patient decision support, and c) helping patients explore preferences and make decisions. This model rests on supporting a process of deliberation, and on understanding that decisions should be influenced by exploring and respecting “what matters most” to patients as individuals, and that this exploration in turn depends on them developing informed preferences.

Motivational interviewing: helping people change

Abstract: Part I: What Is Motivational Interviewing? Conversations about Change. The Spirit of Motivational Interviewing. The Method of Motivational Interviewing. Part II: Engaging: The Relational Foundation. Engagement and Disengagement. Listening: Understanding the Person's Dilemma. Core Interviewing Skills: OARS. Exploring Values and Goals. Part III: Focusing: The Strategic Direction. Why Focus? Finding the Horizon. When Goals Differ. Exchanging Information. Part IV: Evoking: Preparation for Change. Evoking the Person's Own Motivation. Responding to Change Talk. Responding to Sustain Talk and Discord. Evoking Hope and Confidence. Counseling with Neutrality. Developing Discrepancy. Part V: Planning: The Bridge to Change. Developing a Change Plan. Strengthening Commitment. Supporting Change. Part VI: Motivational Interviewing in Everyday Practice. Experiencing Motivational Interviewing. Applying Motivational Interviewing. Integrating Motivational Interviewing. Part VII: Evaluating Motivational Interviewing. Research Evidence and the Evolution of Motivational Interviewing. Evaluating Motivational Conversations. Appendix A: Glossary of Motivational Interviewing Terms. McLouth, Appendix B: A Bibliography of Motivational Interviewing.

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Abstract: The National High Blood Pressure Education Program presents the complete Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Like its predecessors, the purpose is to provide an evidence-based approach to the prevention and management of hypertension. The key messages of this report are these: in those older than age 50, systolic blood pressure (BP) of greater than 140 mm Hg is a more important cardiovascular disease (CVD) risk factor than diastolic BP; beginning at 115/75 mm Hg, CVD risk doubles for each increment of 20/10 mm Hg; those who are normotensive at 55 years of age will have a 90% lifetime risk of developing hypertension; prehypertensive individuals (systolic BP 120-139 mm Hg or diastolic BP 80-89 mm Hg) require health-promoting lifestyle modifications to prevent the progressive rise in blood pressure and CVD; for uncomplicated hypertension, thiazide diuretic should be used in drug treatment for most, either alone or combined with drugs from other classes; this report delineates specific high-risk conditions that are compelling indications for the use of other antihypertensive drug classes (angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, beta-blockers, calcium channel blockers); two or more antihypertensive medications will be required to achieve goal BP (<140/90 mm Hg, or <130/80 mm Hg) for patients with diabetes and chronic kidney disease; for patients whose BP is more than 20 mm Hg above the systolic BP goal or more than 10 mm Hg above the diastolic BP goal, initiation of therapy using two agents, one of which usually will be a thiazide diuretic, should be considered; regardless of therapy or care, hypertension will be controlled only if patients are motivated to stay on their treatment plan. Positive experiences, trust in the clinician, and empathy improve patient motivation and satisfaction. This report serves as a guide, and the committee continues to recognize that the responsible physician's judgment remains paramount.

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Abstract: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC Endorsed by the European Stroke Organisation (ESO)

Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide

Abstract: Without a complete published description of interventions, clinicians and patients cannot reliably implement interventions that are shown to be useful, and other researchers cannot replicate or build on research findings. The quality of description of interventions in publications, however, is remarkably poor. To improve the completeness of reporting, and ultimately the replicability, of interventions, an international group of experts and stakeholders developed the Template for Intervention Description and Replication (TIDieR) checklist and guide. The process involved a literature review for relevant checklists and research, a Delphi survey of an international panel of experts to guide item selection, and a face to face panel meeting. The resultant 12 item TIDieR checklist (brief name, why, what (materials), what (procedure), who provided, how, where, when and how much, tailoring, modifications, how well (planned), how well (actual)) is an extension of the CONSORT 2010 statement (item 5) and the SPIRIT 2013 statement (item 11). While the emphasis of the checklist is on trials, the guidance is intended to apply across all evaluative study designs. This paper presents the TIDieR checklist and guide, with an explanation and elaboration for each item, and examples of good reporting. The TIDieR checklist and guide should improve the reporting of interventions and make it easier for authors to structure accounts of their interventions, reviewers and editors to assess the descriptions, and readers to use the information.

Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report

Abstract: To revise 1998 recommendations on childhood obesity, an Expert Committee, comprised of representatives from 15 professional organizations, appointed experienced scientists and clinicians to 3 writing groups to review the literature and recommend approaches to prevention, assessment, and treatment. Because effective strategies remain poorly defined, the writing groups used both available evidence and expert opinion to develop the recommendations. Primary care providers should universally assess children for obesity risk to improve early identification of elevated BMI, medical risks, and unhealthy eating and physical activity habits. Providers can provide obesity prevention messages for most children and suggest weight control interventions for those with excess weight. The writing groups also recommend changing office systems so that they support efforts to address the problem. BMI should be calculated and plotted at least annually, and the classification should be integrated with other information such as growth pattern, familial obesity, and medical risks to assess the child’s obesity risk. For prevention, the recommendations include both specific eating and physical activity behaviors, which are likely to promote maintenance of healthy weight, but also the use of patient-centered counseling techniques such as motivational interviewing, which helps families identify their own motivation for making change. For assessment, the recommendations include methods to screen for current medical conditions and for future risks, and methods to assess diet and physical activity behaviors. For treatment, the recommendations propose 4 stages of obesity care; the first is brief counseling that can be delivered in a health care office, and subsequent stages require more time and resources. The appropriateness of higher stages is influenced by a patient’s age and degree of excess weight. These recommendations recognize the importance of social and environmental change to reduce the obesity epidemic but also identify ways healthcare providers and health care systems can be part of broader efforts.